Skip to main content

Table 2 Demographic and disease characteristics of study participants

From: A cross-sectional study clarifying profiles of patients with diabetes who discontinued pharmacotherapy: reasons and consequences

Variable Discontinuation
(n = 148)
Continuation
(n = 146)
p value
Gender: male Cases (%) 114 (77) 102 (70) 0.1642
Age (yr) Mean ± SD 54.4 ± 10.1 54.6 ± 9.5 0.8873
Body mass index (%) Mean ± SD 26.3 ± 5.6 26.8 ± 5.8 0.4633
Diabetes duration (yr) Mean ± SD 12.2 ± 7.8 11.5 ± 7.8 0.4543
Discontinuation duration (yr) Mean ± SD 2.6 ± 2.4
Discontinuation ratio (%) Mean ± SD 23.1 ± 22.0
Age at resumption (yr) Mean ± SD 50.9 ± 9.6
Complications Cases (%) 22 (15) 15 (10) 0.2352
Number of medications1 Mean ± SD 4.2 ± 3.4 4.3 ± 3.9 0.7913
Insulin use Cases (%) 24 (16) 21 (14) 0.6082
Hypoglycaemia (episodes per year) Cases (%) 27 (18) 30 (21) 0.6172
Drug-related side effects Cases (%) 34 (23) 34 (23) 0.9492
Familial history of diabetes Cases (%) 75 (51) 62 (43) 0.1582
Current smoking habit Cases (%) 27 (18) 31 (21) 0.5202
HbA1c (%) (mmol/mol) Mean ± SD 7.4 ± 1.4
58.3 ± 16.4
7.2 ± 1.1
55.1 ± 11.7
0.1313
HbA1c under control Cases (%) 79 (53) 78 (53) 0.9942
MMAS-8
adherence
classification
High (8) Cases (%) 30 (20) 51 (35) 0.0172
Medium (≥ 6 and < 8) Cases (%) 57 (39) 43 (30)
Low (< 6) Cases (%) 61 (41) 52 (36)
  1. 1Number of medication for diabetes 2Pearson chi-square test (2-sided). 3ANOVA (2-sided)